Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;2(9):e302.
doi: 10.1371/journal.pmed.0020302. Epub 2005 Sep 8.

A breakthrough in R&D for neglected diseases: new ways to get the drugs we need

Mary Moran  1
Affiliations

A breakthrough in R&D for neglected diseases: new ways to get the drugs we need

Mary Moran. PLoS Med. 2005 Sep.

Erratum in

  • PLoS Med. 2005 Oct;2(10):e376

Abstract

New research suggests that long-held beliefs on neglected disease drug development activity are no longer accurate.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author declares that she has no competing interests.

Figures

Figure 1
Figure 1. Active Neglected-Disease Drug Projects by Institution* (Dec 2004)
DNDi, Drugs for Neglected Diseases Initiative; IOWH, Institute for OneWorld Health; MMV, Medicines for Malaria Venture; ND, neglected diseases.
Figure 2
Figure 2. The R&D Drug Landscape for Neglected Diseases (Dec 2004)
Figure 3
Figure 3. PPP Timelines
DNDi, Drugs for Neglected Diseases Initiative; MMV, Medicines for Malaria Venture.
Figure 4
Figure 4. Public Timelines
WRAIR, Walter Reed Army Institute of Research.
See this image and copyright information in PMC

Comment in

References

    1. Pecoul B, Chirac P, Trouiller P, Pinel J. Access to essential drugs in poor countries: A lost battle? JAMA. 1999;281:361–367. - PubMed
    1. Commission for Africa. Final report: “Our common interest”. 2005 March 2005. Available: http://www.commissionforafrica.org/english/report/thereport/english/11-0.... Accessed 29 July 2005.
    1. DiMasi J, Hansen R, Grabowski H. The price of innovation: New estimates of drug development costs. J Health Econ. 2003;22:325–330. - PubMed
    1. Shibuya K, Bernard C, Ezzati M, Mathers C. Global burden of onchocerciasis in the year 2000: Summary of methods and data sources [draft] Geneva: Epidemiology and Burden for Disease (EBD); 2005. Global Programme on Evidence for Health Policy (GPE), World Health Organization.
    1. Chitsulo L, Loverde P, Engels D. Schistosomiasis. Nat Rev Microbiol. 2004;2:12–13. - PubMed

Publication types

MeSH terms

Substances